共 126 条
[91]
Pialeux G., Fournier S., Moulignier A., Et al., CNS as a sanctuary for HV-1 nfection despite treatment with zidovudine, lamivudine and indinavir, AIDS, 11, pp. 1302-1303, (1997)
[92]
Gisslen M., Norkrans G., Svennerholm B., HIV-1 RNA detectable with ultrasensitive PCR in plasma but not in CSF during combination treatment with zidovudine, lamivudine and indinavir, AIDS, 12, pp. 114-115, (1998)
[93]
Pomerantz R.J., Residual HV-1 infection during antiretroviral therapy: The challenge of viral persistence, AIDS, 15, pp. 1201-1211, (2001)
[94]
Stingele K., Haas J., Zimmermann T., Et al., Independent HV replication in paired CSF and blood viral isolates during antiretroviral therapy, Neurology, 56, pp. 355-361, (2001)
[95]
McArthur J.C., Sacktor N., Selnes O., HIV-associated dementia, Sem. Neurol., 19, pp. 129-150, (1999)
[96]
Enting R.H., Hoetelmans M.W., Lange J.M., Et al., Antiretroviral drugs and the CNS, AIDS, 12, pp. 1941-1955, (1998)
[97]
Pizzo P., Eddy J., Falloon J., Et al., Effect of continuous IV infusion of zidovudine n children with symptomatic HIV infection, N. Engl. J. Med., 319, pp. 889-896, (1988)
[98]
McKinney R.E., Maha M.A., Connor E.M., Et al., A multicenter trial of oral zidovudine in children with HIV disease, N. Engl. J. Med., 324, pp. 1018-1025, (1991)
[99]
Arendt G., Ciesen H.V., Hefter H., Theisen A., Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection, AIDS, 15, pp. 493-500, (2001)
[100]
Kline M.W., Dunkle L.M., Church J.A., Et al., A phase I/II evaluation of stavudine (d4T) in children with HIV infection, Pediatrics, 96, pp. 247-252, (1995)